{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:36:55Z","timestamp":1792100215020,"version":"4.4.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1111\/bjd.13989","type":"journal-article","created":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T19:31:49Z","timestamp":1450726309000},"page":"1250-1254","source":"Crossref","is-referenced-by-count":59,"title":["Epidermal necrolysis: 60\u00a0years of errors and advances"],"prefix":"10.1093","volume":"173","author":[{"given":"Y.K.","family":"Heng","sequence":"first","affiliation":[{"name":"National Skin Centre; 1 Mandalay Road Singapore 308205"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.Y.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Singapore General Hospital; Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-C.","family":"Roujeau","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Est Cr\u00e9teil; Cr\u00e9teil France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,11,26]]},"reference":[{"key":"10.1111\/bjd.13989-BIB0001|bjd13989-cit-0001","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","article-title":"Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study","volume":"138","author":"Auquier-Dunant","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13989-BIB0002|bjd13989-cit-0002","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2133.1956.tb12766.x","article-title":"Toxic epidermal necrolysis: an eruption resembling scalding of the skin","volume":"68","author":"Lyell","year":"1956","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13989-BIB0003|bjd13989-cit-0003","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1365-2133.1990.tb06275.x","article-title":"Requiem for toxic epidermal necrolysis","volume":"122","author":"Lyell","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13989-BIB0004|bjd13989-cit-0004","first-page":"55","volume-title":"Atlas der Hautkrankheiten","volume":"6","author":"Hebra","year":"1866"},{"key":"10.1111\/bjd.13989-BIB0005|bjd13989-cit-0005","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archpedi.1922.04120120077005","article-title":"A new eruptive fever associated with stomatitis and ophthalmia. Report of two cases in children","volume":"24","author":"Stevens","year":"1922","journal-title":"Am J Dis Child"},{"key":"10.1111\/bjd.13989-BIB0006|bjd13989-cit-0006","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0190-9622(83)80003-6","article-title":"Erythema multiforme: a critical review of characteristics, diagnostic criteria and causes","volume":"8","author":"Huff","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13989-BIB0007|bjd13989-cit-0007","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2133.1979.tb03571.x","article-title":"Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal","volume":"100","author":"Lyell","year":"1979","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13989-BIB0008|bjd13989-cit-0008","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"A clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13989-BIB0009|bjd13989-cit-0009","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0190-9622(90)70333-D","article-title":"Toxic epidermal necrolysis (Lyell syndrome)","volume":"23","author":"Roujeau","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13989-BIB0010|bjd13989-cit-0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/bjd.13989-BIB0011|bjd13989-cit-0011","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13989-BIB0012|bjd13989-cit-0012","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.13989-BIB0013|bjd13989-cit-0013","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1542\/peds.2010-3322","article-title":"Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children","volume":"128","author":"Finkelstein","year":"2011","journal-title":"Pediatrics"},{"key":"10.1111\/bjd.13989-BIB0014|bjd13989-cit-0014","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","article-title":"Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study","volume":"58","author":"Schneck","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13989-BIB0015|bjd13989-cit-0015","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/jid.2012.510","article-title":"RegiSCAR study group. Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"133","author":"Sekula","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13989-BIB0016|bjd13989-cit-0016","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1523-1747.2002.01622.x","article-title":"Drug specific cytotoxic T cells in the skin lesions of a patient with toxic epidermal necrolysis","volume":"118","author":"Nassif","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13989-BIB0017|bjd13989-cit-0017","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","article-title":"Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells","volume":"114","author":"Nassif","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.13989-BIB0018|bjd13989-cit-0018","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med"},{"key":"10.1111\/bjd.13989-BIB0019|bjd13989-cit-0019","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-0625.2010.01176.x","article-title":"Death ligand TRAIL, secreted by CD1a+ and CD14+ cells in blister fluids is involved in killing keratinocytes in toxic epidermal necrolysis","volume":"20","author":"Araujo","year":"2011","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.13989-BIB0020|bjd13989-cit-0020","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.0022-202X.2004.23439.x","article-title":"Evaluation of the potential role of cytokines in toxic epidermal necrolysis","volume":"123","author":"Nassif","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13989-BIB0021|bjd13989-cit-0021","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"10.1111\/bjd.13989-BIB0022|bjd13989-cit-0022","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/archderm.136.3.323","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?","volume":"136","author":"Garcia-Doval","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13989-BIB0023|bjd13989-cit-0023","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1046\/j.1365-2230.2001.00910.x","article-title":"Successful dexamethasone pulse therapy in a toxic epidermal necrolysis (TEN) patient featuring recurrent TEN to oxazepam","volume":"26","author":"Meer","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.13989-BIB0024|bjd13989-cit-0024","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1365-2133.2010.09863.x","article-title":"Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"163","author":"Valeyrie-Allanore","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13989-BIB0025|bjd13989-cit-0025","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0190-9622(08)80969-3","article-title":"Efficacy of cyclophosphamide in toxic epidermal necrolysis, clinical and pathophysiologic aspects","volume":"25","author":"Heng","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13989-BIB0026|bjd13989-cit-0026","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1001\/archderm.1985.01660120074023","article-title":"Plasmapheresis in severe drug-induced toxic epidermal necrolysis","volume":"121","author":"Kamanabroo","year":"1985","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13989-BIB0027|bjd13989-cit-0027","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jaci.2005.06.029","article-title":"Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment","volume":"116","author":"Hunger","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.13989-BIB0028|bjd13989-cit-0028","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2133.1997.tb02175.x","article-title":"Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis. Treatment with N-acetylcysteine","volume":"136","author":"Redondo","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13989-BIB0029|bjd13989-cit-0029","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2133.2012.11074.x","article-title":"The role of prior corticosteroid use on the clinical course of Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control analysis of patients selected from the multinational EuroSCAR and RegiSCAR studies","volume":"167","author":"Lee","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13989-BIB0030|bjd13989-cit-0030","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(98)02197-7","article-title":"Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis","volume":"352","author":"Wolkenstein","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/bjd.13989-BIB0031|bjd13989-cit-0031","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/2042098611404094","article-title":"Systematic review of treatments for Stevens-Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality","volume":"2","author":"Roujeau","year":"2011","journal-title":"Ther Adv Drug Saf"},{"key":"10.1111\/bjd.13989-BIB0032|bjd13989-cit-0032","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2133.2012.10965.x","article-title":"The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis","volume":"167","author":"Huang","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13989-BIB0033|bjd13989-cit-0033","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/bjd.12607","article-title":"The role of intravenous immunoglobulin in toxic epidermal necrolysis: a retrospective analysis of 64 patients managed in a specialized centre","volume":"169","author":"Lee","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13989-BIB0034|bjd13989-cit-0034","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13989-BIB0035|bjd13989-cit-0035","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0895-4356(95)00004-N","article-title":"An international collaborative case-control study of severe cutaneous adverse reactions (SCAR). Design and methods","volume":"48","author":"Kelly","year":"1995","journal-title":"J Clin Epidemiol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.13989","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.13989\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:16:32Z","timestamp":1676384192000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/173\/5\/1250\/6616951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.13989","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}